İlyas Şahin

2.4k total citations · 1 hit paper
70 papers, 1.3k citations indexed

About

İlyas Şahin is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, İlyas Şahin has authored 70 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 15 papers in Cancer Research and 14 papers in Surgery. Recurrent topics in İlyas Şahin's work include Cancer Immunotherapy and Biomarkers (9 papers), Multiple Myeloma Research and Treatments (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). İlyas Şahin is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Multiple Myeloma Research and Treatments (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). İlyas Şahin collaborates with scholars based in United States, Türkiye and Italy. İlyas Şahin's co-authors include Ali Zarrinpar, Sergio Duarte, Irene M. Ghobrial, Michele Moschetta, Yuji Mishima, Aldo M. Roccaro, Adam J. Olszewski, Thomas Ollila, Salomon Manier and Antonio Sacco and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

İlyas Şahin

64 papers receiving 1.3k citations

Hit Papers

Mechanisms of drug resistance in HCC 2023 2026 2024 2025 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
İlyas Şahin United States 19 516 339 273 269 244 70 1.3k
Harald Thidemann Johansen Norway 22 445 0.9× 256 0.8× 247 0.9× 109 0.4× 329 1.3× 72 1.4k
Ηλίας Δράκος United States 28 1.1k 2.1× 648 1.9× 420 1.5× 457 1.7× 314 1.3× 71 2.1k
Giovanni Abbadessa United States 24 732 1.4× 582 1.7× 200 0.7× 264 1.0× 170 0.7× 99 1.7k
Stefan Schweyer Germany 26 967 1.9× 320 0.9× 303 1.1× 164 0.6× 197 0.8× 74 2.0k
Delphine Bonnet France 17 250 0.5× 241 0.7× 124 0.5× 205 0.8× 119 0.5× 53 1.0k
Catriona McKenzie Australia 17 460 0.9× 430 1.3× 374 1.4× 101 0.4× 130 0.5× 51 1.6k
Manujendra N. Saha Canada 20 610 1.2× 333 1.0× 145 0.5× 119 0.4× 185 0.8× 32 1.1k
Runqing Lu United States 23 759 1.5× 444 1.3× 797 2.9× 223 0.8× 233 1.0× 36 2.0k
Weiping Zeng United States 21 780 1.5× 579 1.7× 514 1.9× 110 0.4× 112 0.5× 51 1.8k
Faribourz Payvandi United States 15 815 1.6× 479 1.4× 344 1.3× 107 0.4× 202 0.8× 19 1.6k

Countries citing papers authored by İlyas Şahin

Since Specialization
Citations

This map shows the geographic impact of İlyas Şahin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İlyas Şahin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İlyas Şahin more than expected).

Fields of papers citing papers by İlyas Şahin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İlyas Şahin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İlyas Şahin. The network helps show where İlyas Şahin may publish in the future.

Co-authorship network of co-authors of İlyas Şahin

This figure shows the co-authorship network connecting the top 25 collaborators of İlyas Şahin. A scholar is included among the top collaborators of İlyas Şahin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İlyas Şahin. İlyas Şahin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zarrinpar, Ali, et al.. (2024). Immune checkpoint inhibitors in the posttransplant landscape of HCC: A systematic literature review. Liver Transplantation. 32(2). 283–295. 4 indexed citations
2.
Özer, Muhammet, et al.. (2024). Clinicopathologic and treatment characteristics of mixed hepatocellular carcinoma-intrahepatic cholangiocarcinoma (HCC-ICC).. Journal of Clinical Oncology. 42(16_suppl). e16218–e16218.
5.
Özer, Muhammet, et al.. (2023). Adoptive Cell Therapy in Hepatocellular Carcinoma: A Review of Clinical Trials. Cancers. 15(6). 1808–1808. 22 indexed citations
6.
Ayasun, Rüveyda, Muhammet Özer, & İlyas Şahin. (2023). The Role of HER2 Status in the Biliary Tract Cancers. Cancers. 15(9). 2628–2628. 12 indexed citations
7.
Özer, Muhammet, Rüveyda Ayasun, Jesus C. Fabregas, et al.. (2023). Effects of Clinical and Tumor Characteristics on Survival in Patients with Hepatocellular Carcinoma with Bone Metastasis. Journal of Hepatocellular Carcinoma. Volume 10. 1129–1141. 4 indexed citations
8.
Duarte, Sergio, et al.. (2023). Methylated ctDNA Quantification: Noninvasive Approach to Monitoring Hepatocellular Carcinoma Burden. Journal of the American College of Surgeons. 238(4). 770–778. 11 indexed citations
9.
King, William P., et al.. (2022). Advanced Hepatocellular Carcinoma in Adults Without Cirrhosis: A Single-Institution Retrospective Review. SHILAP Revista de lepidopterología. Volume 9. 1299–1307. 2 indexed citations
10.
Ollila, Thomas, İlyas Şahin, & Adam J. Olszewski. (2019). <p>Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma</p>. OncoTargets and Therapy. Volume 12. 1085–1094. 55 indexed citations
11.
Olszewski, Adam J., Anna Chorzalska, Annette S. Kim, et al.. (2018). Recipients of Myelotoxic Chemotherapy Have Increased Prevalence of Clonal Hematopoiesis of Indeterminate Potential (CHIP) with a Typical Distribution of Chip-Associated Mutations. Blood. 132(Supplement 1). 3841–3841. 2 indexed citations
12.
Ordikhani, Farideh, et al.. (2016). Drug Delivery Approaches for the Treatment of Cervical Cancer. Pharmaceutics. 8(3). 23–23. 74 indexed citations
13.
Şahin, İlyas, Houry Leblebjian, Steven P. Treon, & Irene M. Ghobrial. (2014). Waldenström macroglobulinemia: from biology to treatment. Expert Review of Hematology. 7(1). 157–168. 12 indexed citations
14.
Manier, Salomon, Siobhan Glavey, Antonio Sacco, et al.. (2013). Mirna Expression Profiling and Proteomic Analysis Of Circulating Exosomes From Multiple Myeloma Patients. Blood. 122(21). 3086–3086. 1 indexed citations
15.
Dızdar, Ömer, et al.. (2013). Outcomes of locally advanced breast cancer patients with ≥10 positive axillary lymph nodes. Medical Oncology. 30(3). 615–615. 24 indexed citations
16.
Doğan, Nasuh Utku, et al.. (2013). Cancer of cervical stump diagnosed in a woman with chronic myelogenous leukaemia. Journal of Obstetrics and Gynaecology. 33(4). 428–429. 2 indexed citations
17.
Şahin, İlyas, et al.. (2012). A Rare Case of Collision Tumor: Coexistence of Adrenocortical Adenoma and Pheochromocytoma in the Same Adrenal Gland. Journal of Medical Cases. 3(1). 63–67. 2 indexed citations
18.
Şahin, İlyas, et al.. (2010). Aspirin intake may prevent metastasis in patients with triple-negative breast cancer. Medical Oncology. 28(4). 1308–1310. 4 indexed citations
19.
Ekici, Arif B., et al.. (2001). Endometrial patterns and endocrinologic characteristics of asymptomatic menopausal women. Gynecological Endocrinology. 15(1). 63–67. 2 indexed citations
20.
Şahin, İlyas, et al.. (2000). Nucleated red blood cells as a marker in acute and chronic fetal asphyxia. International Journal of Gynecology & Obstetrics. 71(2). 113–118. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026